Anandamide increases the differentiation of rat adipocytes and causes PPARgamma and CB1 receptor upregulation (Q39835267)

15 September 2017

title

Anandamide increases the differentiation of rat adipocytes and causes PPARgamma and CB1 receptor upregulation (English)

1 reference

15 September 2017

0 references

0 references

1 reference

Sevasti Karaliota

1

1 reference

15 September 2017

Athanasia Siafaka-Kapadai

2

1 reference

15 September 2017

Chrisanthi Gontinou

3

1 reference

15 September 2017

Katerina Psarra

4

1 reference

15 September 2017

Mary Mavri-Vavayanni

5

1 reference

15 September 2017

publication date

18 June 2009

1 reference

15 September 2017

1 reference

15 September 2017

volume

17

1 reference

15 September 2017

issue

10

1 reference

15 September 2017

page(s)

1830-1838

1 reference

Peroxisome proliferator-activated receptor gamma and metabolic disease.

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Targeting the endocannabinoid system: to enhance or reduce?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Dual effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Cannabinoid physiology and pharmacology: 30 years of progress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Cellular accumulation of anandamide: consensus and controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Non-redundant functions of cyclooxygenases: oxygenation of endocannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

The neurobiology and evolution of cannabinoid signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Anandamide metabolism by Tetrahymena pyriformis in vitro. Characterization and identification of a 66 kDa fatty acid amidohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Endocannabinoid control of food intake and energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Leptin-regulated endocannabinoids are involved in maintaining food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Endocannabinoids in adipocytes during differentiation and their role in glucose uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Effects of isomers of conjugated linoleic acid on porcine adipocyte growth and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Simple flow cytometric method used to assess lipid accumulation in fat cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Monoclonal antibody 4C5 immunostains human melanomas and inhibits melanoma cell invasion and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

The emerging role of the endocannabinoid system in endocrine regulation and energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

CB1- and CB2-cannabinoid receptor-independent lipolysis induced by WIN 55,212-2 in male rat adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Activation of the peripheral endocannabinoid system in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

The cannabinoid system and immune modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor alpha ligand-binding domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

The fatty acid amide hydrolase (FAAH).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Modulation of anxiety through blockade of anandamide hydrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Induction of cyclooxygenase-2 by anandamide in cerebral microvascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Differences in the pharmacological properties of rat and chicken brain fatty acid amidohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Understanding adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Effect of polyunsaturated fatty acids on endocannabinoid and N-acyl-ethanolamine levels in mouse adipocytes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Altered expression of C/EBP family members results in decreased adipogenesis with aging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

PPARgamma ligands induce prostaglandin production in vascular smooth muscle cells: indomethacin acts as a peroxisome proliferator-activated receptor-gamma antagonist

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.177

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2009.177

1 reference

15 September 2017

1 reference